Literature DB >> 27306170

How iPS cells changed the world.

Megan Scudellari.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27306170     DOI： 10.1038/534310a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  14 in total

1.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors:  Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

2.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

3.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

4.  Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.

Authors:  Dominik Paquet; Dylan Kwart; Antonia Chen; Andrew Sproul; Samson Jacob; Shaun Teo; Kimberly Moore Olsen; Andrew Gregg; Scott Noggle; Marc Tessier-Lavigne
Journal:  Nature       Date:  2016-04-27       Impact factor: 49.962

5.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

6.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

7.  Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure.

Authors:  Xuyu Qian; Ha Nam Nguyen; Mingxi M Song; Christopher Hadiono; Sarah C Ogden; Christy Hammack; Bing Yao; Gregory R Hamersky; Fadi Jacob; Chun Zhong; Ki-Jun Yoon; William Jeang; Li Lin; Yujing Li; Jai Thakor; Daniel A Berg; Ce Zhang; Eunchai Kang; Michael Chickering; David Nauen; Cheng-Ying Ho; Zhexing Wen; Kimberly M Christian; Pei-Yong Shi; Brady J Maher; Hao Wu; Peng Jin; Hengli Tang; Hongjun Song; Guo-Li Ming
Journal:  Cell       Date:  2016-04-22       Impact factor: 41.582

8.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

9.  Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgia.

Authors:  Lishuang Cao; Aoibhinn McDonnell; Anja Nitzsche; Aristos Alexandrou; Pierre-Philippe Saintot; Alexandre J C Loucif; Adam R Brown; Gareth Young; Malgorzata Mis; Andrew Randall; Stephen G Waxman; Philip Stanley; Simon Kirby; Sanela Tarabar; Alex Gutteridge; Richard Butt; Ruth M McKernan; Paul Whiting; Zahid Ali; James Bilsland; Edward B Stevens
Journal:  Sci Transl Med       Date:  2016-04-20       Impact factor: 17.956

10.  Duplication of TBK1 Stimulates Autophagy in iPSC-derived Retinal Cells from a Patient with Normal Tension Glaucoma.

Authors:  Budd A Tucker; Frances Solivan-Timpe; Ben R Roos; Kristin R Anfinson; Alan L Robin; Luke A Wiley; Robert F Mullins; John H Fingert
Journal:  J Stem Cell Res Ther       Date:  2014-01-25
View more
  39 in total

Review 1.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

Review 2.  Opportunities and challenges of translational 3D bioprinting.

Authors:  Sean V Murphy; Paolo De Coppi; Anthony Atala
Journal:  Nat Biomed Eng       Date:  2019-11-06       Impact factor: 25.671

Review 3.  Induced pluripotent stem cell technology: a decade of progress.

Authors:  Yanhong Shi; Haruhisa Inoue; Joseph C Wu; Shinya Yamanaka
Journal:  Nat Rev Drug Discov       Date:  2016-12-16       Impact factor: 84.694

Review 4.  MicroRNAs: Important Regulators of Induced Pluripotent Stem Cell Generation and Differentiation.

Authors:  Zhao-Lin Zeng; Xiao-Long Lin; Li-Lan Tan; Ya-Mi Liu; Kai Qu; Zuo Wang
Journal:  Stem Cell Rev Rep       Date:  2018-02       Impact factor: 5.739

5.  Blood Derived Induced Pluripotent Stem Cells (iPSCs): Benefits, Challenges and the Road Ahead.

Authors:  Holly N Cukier; Jimmy El Hokayem; Derek M Dykxhoorn
Journal:  J Alzheimers Dis Parkinsonism       Date:  2016-10-25

Review 6.  Cell therapy for the treatment of sepsis and acute respiratory distress syndrome.

Authors:  Raquel Guillamat-Prats; Marta Camprubí-Rimblas; Josep Bringué; Neus Tantinyà; Antonio Artigas
Journal:  Ann Transl Med       Date:  2017-11

Review 7.  Biomanufacturing for clinically advanced cell therapies.

Authors:  Ayesha Aijaz; Matthew Li; David Smith; Danika Khong; Courtney LeBlon; Owen S Fenton; Ronke M Olabisi; Steven Libutti; Jay Tischfield; Marcela V Maus; Robert Deans; Rita N Barcia; Daniel G Anderson; Jerome Ritz; Robert Preti; Biju Parekkadan
Journal:  Nat Biomed Eng       Date:  2018-06-11       Impact factor: 25.671

8.  Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models.

Authors:  Bin Song; Young Cha; Sanghyeok Ko; Jeha Jeon; Nayeon Lee; Hyemyung Seo; Kyung-Joon Park; In-Hee Lee; Claudia Lopes; Melissa Feitosa; María José Luna; Jin Hyuk Jung; Jisun Kim; Dabin Hwang; Bruce M Cohen; Martin H Teicher; Pierre Leblanc; Bob S Carter; Jeffrey H Kordower; Vadim Y Bolshakov; Sek Won Kong; Jeffrey S Schweitzer; Kwang-Soo Kim
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

Review 9.  Tau-based therapies in neurodegeneration: opportunities and challenges.

Authors:  Chuanzhou Li; Jürgen Götz
Journal:  Nat Rev Drug Discov       Date:  2017-10-06       Impact factor: 84.694

Review 10.  Recognizing the ethical implications of stem cell research: A call for broadening the scope.

Authors:  Lars S Assen; Karin R Jongsma; Rosario Isasi; Marianna A Tryfonidou; Annelien L Bredenoord
Journal:  Stem Cell Reports       Date:  2021-07-01       Impact factor: 7.765
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.